InPlay from Briefing.com

Posted: Published on November 27th, 2012

This post was added by Dr. Richardson

5:25 pm Robbins & Myers certifies substantial compliance with second request in connection with NOV merger (RBN)

Co announced that it and National Oilwell Varco (NOV) have certified substantial compliance with the U.S. Department of Justice's request for information (commonly called a "second request") pursuant to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR Act"), in connection with the proposed merger transaction in which National Oilwell Varco, Inc. would acquire all of the outstanding shares of Robbins & Myers for $60.00 per share in cash. Pursuant to the HSR Act, the premerger waiting period will expire at 11:59 p.m., Eastern Time, on December 27, 2012 (which is thirty days after the certification of substantial compliance), absent a challenge by the U.S. Department of Justice.

Robbins & Myers also announced today that it is delaying its 2013 annual meeting of shareholders to March 26, 2013.

5:20 pm Zoltek misses by $0.01, misses on revs (ZOLT)

Reports Q4 (Sep) earnings of $0.13 per share, $0.01 worse than the Capital IQ Consensus Estimate of $0.14; revenues rose 2.6% year/year to $44.2 mln vs the $46.67 mln consensus.

5:19 pm Medley Capital announces offering of 5 mln shares of common stock (MCC)

Co announced the commencement of a registered public offering of 5,000,000 shares of its common stock. The Company intends to use the net proceeds from the offering to fund new investment opportunities, repay the outstanding indebtedness under its credit facility and for general corporate purposes.

5:18 pm Copart reports EPS in-line, revs in-line (CPRT)

Reports Q1 (Oct) earnings of $0.36 per share, in-line with the Capital IQ Consensus Estimate consensus of $0.36; revenues rose 5.9% year/year to $238.87 mln vs the $236.96 mln consensus.During the quarter the Company repurchased 500,000 shares of its common stock at a weighted average price of $27.77 per share under its share repurchase program. At the end of the quarter, Copart had 47,713,218 shares available for repurchase under its share repurchase program.

5:15 pm McCormick announces 9.7% increase in quarterly dividend to $0.34 from $0.31 per share (MKC)

Read the original:
InPlay from Briefing.com

Related Posts
This entry was posted in FDA Stem Cell Trials. Bookmark the permalink.

Comments are closed.